Atlas Trials

A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Clinical trial NCT06074484 · UNKNOWN

Trial details

NCT number
NCT06074484
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Muscle Invasive Bladder Carcinoma
Start date
2023-09-10
Primary completion
2024-08-10
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.